| Product NDC: | 13537-124 |
| Proprietary Name: | CYZONE |
| Non Proprietary Name: | Octinoxate and Titanium Dioxide |
| Active Ingredient(s): | .06; .008 g/g; g/g & nbsp; Octinoxate and Titanium Dioxide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13537-124 |
| Labeler Name: | Ventura Corporation Ltd. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20111213 |
| Package NDC: | 13537-124-01 |
| Package Description: | 1 TUBE in 1 BAG (13537-124-01) > 27 g in 1 TUBE |
| NDC Code | 13537-124-01 |
| Proprietary Name | CYZONE |
| Package Description | 1 TUBE in 1 BAG (13537-124-01) > 27 g in 1 TUBE |
| Product NDC | 13537-124 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate and Titanium Dioxide |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20111213 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura Corporation Ltd. |
| Substance Name | OCTINOXATE; TITANIUM DIOXIDE |
| Strength Number | .06; .008 |
| Strength Unit | g/g; g/g |
| Pharmaceutical Classes |